Skip to main content

Table 1 Descriptive statistics

From: An observational study of socioeconomic and clinical gradients among diabetes patients hospitalized for avoidable causes: evidence of underlying health disparities in China?

  

Reasons for inpatient admission

Test of difference in mean†

All observations

Newly diagnosed

Treatment-experienced

 

Variable

Mean

Std dev

Mean

Std dev

Mean

Std dev

Diff or ratio

95% CI

Panel A: Sir Run Run Shaw Hospital

 

(N = 960)

(N = 134)

(N = 849)

  

Patient age

55.60

12.89

49.91

12.18

56.52

12.78

-6.61

[-8.93 - -4.29]

Female

0.43

 

0.28

 

0.46

 

0.60

[0.45 - 0.80]

< High School

0.58

 

0.61

 

0.57

 

1.07

[0.92 - 1.24]

Insured

0.20

 

0.19

 

0.21

 

0.91

[0.62 - 1.32]

Semi-insured

0.44

 

0.42

 

0.44

 

0.95

[0.77 - 1.17]

Uninsured

0.36

 

0.40

 

0.35

 

1.12

[0.89 - 1.41]

Urban

0.44

 

0.44

 

0.45

 

0.99

[0.80 - 1.21]

County/town

0.18

 

0.15

 

0.18

 

0.83

[0.54 - 1.27]

Village

0.38

 

0.41

 

0.37

 

1.10

[0.88 - 1.37]

Married

0.97

 

0.97

 

0.97

 

1.00

[0.97 - 1.04]

Current smoker

0.26

 

0.34

 

0.24

 

1.41

[1.08 - 1.84]

Duration of DM (months)

67.30

64.42

4.69

9.69

77.47

63.78

-72.78

[-83.61 - -61.94]

BMI (kg/m2)

23.90

4.00

24.78

5.26

23.76

3.74

1.02

[0.27 - 1.77]

Fast. blood sugar (mg/dl)

163.95

66.28

186.60

70.91

160.30

64.90

26.30

[13.88 - 38.72]

Triglyceride mg/dl

201.88

209.51

242.83

265.11

195.37

198.67

47.46

[8.88 - 86.03]

Total cholesterol mg/dl

175.18

44.80

186.16

47.25

173.43

44.17

12.73

[4.50 - 20.96]

Plasma LDL-C mg/dl

103.59

39.81

109.19

33.72

102.72

40.62

6.47

[-1.00 - 13.95]

AST IU/L

27.79

26.05

37.66

48.13

26.21

20.02

11.45

[6.71 - 16.19]

ALT IU/L

30.52

30.51

40.87

36.31

28.86

29.16

12.01

[6.45 - 17.58]

Creatinine mg/dl

0.87

0.55

0.79

0.21

0.88

0.58

-0.10

[-0.20 - 0.003]

BUN mg/dl

15.87

7.77

14.55

5.15

16.08

8.10

-1.53

[-2.96 - -0.11]

eGFR ml/min/1.73 M2

101.39

34.54

111.05

31.22

99.84

34.81

11.22

[4.90 - 17.53]

HbA1c %

8.70

2.82

10.40

2.22

8.41

2.81

1.99

[1.48 - 2.50]

Complications upon diagnosis

0.32

 

0.41

 

0.30

 

1.35

[1.07 - 1.69]

Chronic complications

0.83

 

0.75

 

0.84

 

0.89

[0.80 - 0.98]

UKPDS CHD risk

24.63

0.69

18.77

1.39

25.59

20.97

-6.82

[-10.66 - -2.97]

UKPDS stroke risk

15.00

0.68

4.34

0.54

16.69

0.77

-12.35

[-16.16 - -8.55]

Drug expenditures

3,100.82

4,588.62

2336.80

2770.30

3231.51

4810.51

-894.71

[-1735.13 - -54.30]

Diagnostic test expenditures

2,106.74

1,131.80

1976.92

873.45

2132.77

1163.81

-155.85

[-362.73 - 51.02]

Surgical expenditures

96.57

456.74

57.44

287.07

103.12

478.82

-45.67

[-129.50 - 38.16]

Hospital room expenditures

693.40

1,039.34

622.01

931.19

706.59

1056.48

-84.58

[-275.30 - 106.14]

Therapy expenditures

309.89

1,625.24

176.82

359.85

332.10

1746.37

-155.28

[-453.59 - 143.04]

Medical material expenditures

596.51

2,297.50

344.97

386.96

638.50

2471.13

-293.53

[-715.04 - 127.98]

Total expenditures

6,903.93

8,328.53

5473.80

3956.79

7135.94

8815.95

-1,662.14

[-3181.44 - -142.84]

Panel B: Shandong Provincial Hospital

 

(N = 911)

(N = 62)

(N = 849)

  

Patient age

61.61

12.32

52.76

15.47

62.25

11.81

-9.49

[-12.62 - -6.37]

Female

0.50

 

0.44

 

0.50

 

0.88

[0.66 - 1.17]

< High School

Variable not available for Shandong data

Insured

0.09

 

0.06

 

0.10

 

0.60

[0.22 - 1.64]

Semi-insured

0.69

 

0.44

 

0.71

 

0.62

[0.47 - 0.82]

Uninsured

0.21

 

0.50

 

0.19

 

2.63

[1.98 - 3.50]

Urban

0.88

 

0.71

 

0.89

 

0.80

[0.68 - 0.94]

Rural

0.12

 

0.29

 

0.11

 

2.64

[1.71 - 4.07]

Married

0.94

 

0.98

 

0.93

 

1.05

[1.01 - 1.10]

Current smoker

0.18

 

0.16

 

0.19

 

0.84

[0.47 - 1.51]

Duration of DM (months)

120.19

84.49

3.14

2.27

128.74

81.15

-125.60

[-145.83 - -105.36]

BMI (kg/m2)

25.30

3.98

25.47

4.66

25.29

3.92

0.18

[-0.93 - 1.30]

Fasting blood glucose (mg/dl)

157.28

44.21

159.69

38.80

157.10

44.60

2.59

[-7.52 - 12.70]

Plasma triglyceride mg/dl

155.04

133.11

166.06

158.28

154.22

131.13

11.84

[-28.53 - 52.21]

Plasma total cholesterol mg/dl

202.32

49.85

205.76

37.06

202.06

50.68

3.70

[-6.13 - 13.54]

Plasma LDL-C mg/dl

133.72

377.89

122.95

27.70

134.52

391.72

-11.57

[-38.81 - 15.67]

AST IU/L

23.79

26.50

30.09

39.57

23.33

25.26

6.76

[-3.24 - 16.76]

ALT IU/L

22.53

33.10

30.03

43.38

21.99

32.19

8.04

[-2.97 - 19.05]

Creatinine mg/dl

1.01

0.59

0.86

0.19

1.02

0.61

-0.16

[-0.22 - -0.10]

BUN mg/dl

17.44

12.29

14.41

5.81

17.67

12.62

-3.26

[-4.94 - -1.58]

eGFR ml/min/1.73 M2

Variable not available for Shandong Data

HbA1c %

10.05

2.58

11.03

2.93

9.98

2.54

1.05

[0.38 - 1.71]

Complication upon diagnosis

Variable not available for Shandong data

Chronic complications

0.90

 

0.68

 

0.91

 

0.75

[0.63 - 0.89]

UKPDS CHD risk

Variable not available for Shandong data

UKPDS stroke risk

Variable not available for Shandong data

Drug expenditures

12,043.97

9,701.05

7,330.60

4,718.68

12,388.17

9,881.62

-5,057.57

[-7541.92 - -2573.21]

Diagnostic test expenditures

1,431.07

1,165.98

1,431.32

1,256.91

1,430.26

1,159.81

1.06

[-300.13 - 302.26]

Surgical expenditures

32.00

235.56

33.87

266.70

31.86

233.30

2.01

[-58.84 - 62.86]

Hospital room expenditures

935.89

1,642.43

574.35

356.56

962.29

1,695.71

-387.94

[-811.48 - 35.60]

Therapy expenditures

2,587.25

3,869.05

1,926.57

1,115.99

2,635.50

3,992.51

-708.93

[-1707.36 - 289.49]

Medical material expenditures

Variable not available for Shandong data

Total expenditures

17,294.27

13,118.62

11,478.48

5,945.20

17,718.98

13,397.19

-6,240.50

[-9605.00 - -2876.00]

  1. Test of difference in means between the sample of patients hospitalized after diagnosis with no primary care (“newly diagnosed”), compared to patients with hospitalized after having had primary care treatment for diabetes. T-test performed for continuous variables; prevalence ratios given for categorical variables.
  2. Data: Inpatient admissions for Type 2 Diabetes Mellitus at (1) Sir Run Run Shaw Hospital (Hangzhou, China) (Panel A) and (2) Shandong Provincial Hospital (Jinan, China), 2005–2008.
  3. Observations of patients under 18 are excluded.